News & Insights
Sort By
Insights 15 Results
Insights
|April 23, 2025
Client Insight: California AI Transparency Act
CAITA will become effective on January 1, 2026 and will impact both providers of generative AI systems and companies that license and integrate generative AI technology into their offerings
Insights
|November 12, 2024
Client Insight: Demystifying the EU AI Act
On August 1, 2024, the landmark comprehensive artificial intelligence (“AI”) law – the European Union Artificial Intelligence Act – entered into force
Insights
|October 29, 2024
Client Insight: Artificial Intelligence Insights The Current Regulatory Landscape
Gunderson Dettmer spotlights recent regulatory themes impacting the development and use of AI-powered technology and key takeaways for participants of this ecosystem.
Events 9 Results
Events
|April 2, 2025
Webinar: AI Regulatory Landscape Under the New Trump Administration
Gunderson Dettmer Strategic Transactions & Licensing partner, Aaron Rubin, and associate, Christina Chen, hosted a discussion on key updates and forecasts for AI regulation under the Trump administration.
Events
|October 16, 2024
Webinar: AI Terms in Commercial Deals: Negotiating Realistic Terms and Aligning Expectations
Strategic Transactions and Licensing partner Katie Gardner provides insights on important AI-related contract provisions, along with practical pre-contract advice, negotiation tactics and risk management strategies
Events
|May 22, 2024
Webinar: Update on the FTC’s Rule to Ban Employee Non-Competes Nationwide
Gunderson Dettmer Employment & Labor Partner Max Perlman and Strategic Transactions & Licensing Partner Aaron Rubin host a 45-minute update on FTC’s adopted rule banning employers from using non-competes
Client News 8 Results
Client News
|November 20, 2024
Predictive Fitness Announces Strategic Partnership with Ancor Capital Partners
AI-powered fitness software solution, Predictive Fitness, announces its strategic partnership with operations-focused investment firm, Ancor Capital Partners
Client News
|June 3, 2024
Massachusetts-based biotechnology company developing drugs for neurodegenerative diseases, QurAlis, announces strategic license and collaboration agreement with Eli Lilly for rights to develop and commercialize QurAlis’ QRL-204 product
Client News
|June 5, 2023
Gunderson Dettmer Attorneys and Practice Areas Recognized by Chambers USA in 2023 Guide
Sixteen partners across Gunderson Dettmer's U.S. offices were awarded recognition for their knowledge and expertise in each of their individual practice areas by the 2023 Chambers and Partners Guide.
Firm News 28 Results
Firm News
|March 4, 2025
PitchBook 2024 Annual Global League Tables Confirms Gunderson Dettmer as #1 VC Law Firm Globally
For the 11th consecutive year, Gunderson Dettmer has been named the most active VC law firm globally by the 2024 PitchBook Global League Tables.
Firm News
|March 3, 2025
Pitchbook recognizes Gunderson Dettmer as the Most Active Venture Capital Law Firm in Latin America, in the 2024 Annual PitchBook Global League Tables
Firm News
|November 22, 2024
Gunderson Dettmer Recognized as Most Active VC Law Firm in Latin America by PitchBook Q3 2024
PitchBook recognizes Gunderson Dettmer as the Most Active Venture Capital Law Firm in Latin America in the Q3 2024 PitchBook Global League Tables